A recent study published in MedComm – Future Medicine by a research team from Fudan University provides an in-depth ...

Let’s hear the thoughts of some of the world’s leading glioma experts on the data from the study A Multilingual Overview of the INDIGO Study Data (Presented by Clinical Experts in French ...

NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic partnership with CBCC Global Research (CBCC), a premier full ...

An 18-year-old has revealed how she was tested for countless illnesses throughout 2024 until an unusual symptom exposed the ...

Study: Glioma mutational signatures associated with ... high-grade glioblastomas of the isocitrate dehydrogenase 1 gene (IDH1)/IDH2 wild type. A majority of the study participants previously ...

Doctors eventually discovered she had a type of glioma brain tumour called IDH1 mutation astrocytoma. It is typically classed as stage one or two, but a small portion of Ms Barbara’s tumour had ...

The drug candidate – called vorasidenib – is a dual inhibitor of mutated IDH1 and IDH2, which is being developed for a hard-to-treat form of brain cancer called glioma. It was acquired by ...

Moreover, Safusidenib (IDH1 inhibitor) is awaiting Phase 2 data in IDH1-mutant glioma, which could lead to pivotal trials in 2025. The stock has fallen around 30% over the last half year but ...

You would think a brain cancer diagnosis would water down your sense of humour – but this brave young girl is laughing in the ...